SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for UFPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 83.81M
March 31, 2026 79.73M
December 31, 2025 77.44M
September 30, 2025 75.09M
June 30, 2025 71.81M
March 31, 2025 67.03M
December 31, 2024 62.22M
September 30, 2024 56.72M
June 30, 2024 53.40M
March 31, 2024 51.80M
December 31, 2023 50.89M
September 30, 2023 49.66M
June 30, 2023 49.02M
March 31, 2023 48.79M
December 31, 2022 45.80M
September 30, 2022 42.05M
June 30, 2022 37.03M
March 31, 2022 32.18M
December 31, 2021 29.48M
September 30, 2021 27.63M
June 30, 2021 27.62M
March 31, 2021 27.05M
December 31, 2020 27.50M
September 30, 2020 28.23M
June 30, 2020 28.62M
Date Value
March 31, 2020 29.76M
December 31, 2019 29.25M
September 30, 2019 29.43M
June 30, 2019 28.79M
March 31, 2019 28.41M
December 31, 2018 27.76M
September 30, 2018 26.32M
June 30, 2018 25.48M
March 31, 2018 24.12M
December 31, 2017 23.84M
September 30, 2017 23.77M
June 30, 2017 24.11M
March 31, 2017 24.52M
December 31, 2016 24.10M
September 30, 2016 24.01M
June 30, 2016 23.58M
March 31, 2016 23.89M
December 31, 2015 24.01M
September 30, 2015 24.09M
June 30, 2015 24.36M
March 31, 2015 24.05M
December 31, 2014 23.86M
September 30, 2014 23.71M
June 30, 2014 23.52M
March 31, 2014 23.13M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 13.94B
AngioDynamics, Inc. 157.09M
Alphatec Holdings, Inc. 524.06M
AtriCure, Inc. 323.68M
Baxter International, Inc. 2.932B